| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
4.15 -0.13 (-0.03%) |
07-16 16:00 |
|
Open: |
4.3 |
Pre close: |
4.28 |
Target:
|
5.48
|
|
High: |
4.44 |
Low: |
4.01 |
Resistance:
|
4.69
5.93
|
|
Volume: |
107,630 |
Market Cap: |
50M |
Support:
|
2.69
2.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.31
 |
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
4.55  |
Signal(12,26,9): |
0.31 |
|
MA(100): |
3.61 |
Stochastic Oscillator |
%K(14,3):
|
37.46 |
|
MA(250): |
5.15 |
%D(3): |
35.02 |
|
Average Volume(K) |
3-Month: |
11867
|
52-Week |
High:
|
12.02 |
|
10-Days: |
7239 |
Low: |
2.46 |
|
RSI |
RSI(14):
|
50.95 |
Change(%): |
-64.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.916 |
Return on Equity (ttm) |
-89.4 |
Shares Out. (M) |
11.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.5 |
Shares Float (M) |
9.07 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.37 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.72 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.042 |
Shares Short (K) |
16 |
|
Book Value (p.s.) |
1.160 |
EBITDA (p.s.) |
-0.711 |
P/E |
-4.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.89 |
P/S |
1014207936.00 |
|
Operating Margin |
-1703.20 |
Levered Free Cash Flow
(M) |
-4.84 |
P/CF |
-6.43 |
|
|
|
|
|
|
